Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

被引：0

作者：

Zhu, Xiaojian ^{[1
]}

You, Yong ^{[2
]}

Zhang, Yicheng ^{[1
]}

Duan, Minghui ^{[3
,4
]}

Zhu, Yu ^{[5
]}

Liu, Bingcheng ^{[4
,6
]}

Du, Xin ^{[7
]}

Chen, Suning ^{[8
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Hubei, Peoples R China

[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Hubei, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China

[4] Peking Union Med Coll, Beijing, Peoples R China

[5] Nanjing Med Univ, Jiangsu Prov Peoples Hosp Nanjing, Collaborat Innovat Ctr Canc Personalize, Affiliated Hosp 1,Key Lab Hematol, Nanjing, Jiangsu, Peoples R China

[6] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Leukemia Ctr, Tianjin, Peoples R China

[7] Shenzhen Univ, Shenzhen Second Peoples Hosp, Shenzhen Bone Marrow Transplantat Publ Serv Platf, Shenzhen Inst Hematol,Affiliated Hosp 1, Shenzhen, Peoples R China

[8] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-113854

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5443

引用

页数：2

共 50 条

[41] Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system
Malkan, U. Y.
Haznedaroglu, I. C.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (12) : 5493 - 5506
[42] Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia
Shima, Haruko
Kada, Akiko
Tanizawa, Akihiko
Sato, Iori
Tono, Chikako
Ito, Masaki
Yuza, Yuki
Watanabe, Akihiro
Kamibeppu, Kiyoko
Uryu, Hideko
Koh, Katsuyoshi
Imai, Chihaya
Yoshida, Nao
Koga, Yuhki
Fujita, Naoto
Saito, Akiko M.
Adachi, Souichi
Ishii, Eiichi
Shimada, Hiroyuki
PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
[43] The Association of Tyrosine Kinase Inhibitors with Obesity in Chronic Myeloid Leukemia
Rajan, Raeesha
Karia, Esha
Samaan, M. Constantine
Balakumaran, Janatani
Golemiec, Breanne
Spatafora, Laura
Banfield, Laura
Athale, Uma
Thabane, Lehana
Fleming, Adam
Samaan, Constantine
OBESITY, 2021, 29 : 172 - 172
[44] Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia
Campiotti, Leonardo
Bolzacchini, Elena
Sutter, Matteo Basilio
Maresca, Andrea Maria
Grandi, Anna Maria
Guasti, Luigina
INTERNAL AND EMERGENCY MEDICINE, 2018, 13 (08) : 1337 - 1339
[45] Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children
Phillips, Lia N.
Hijiya, Nobuko
PEDIATRIC DRUGS, 2021, 23 (03) : 241 - 251
[46] The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia
Ata, Fateen
Ghasoub, Rola
Benkhadra, Maria
Fernyhough, Liam
Aldapt, Mahmood
Omar, Nabil E.
Nashwan, Abdulqadir
Mushtaq, Kamran
Yassin, Mohamed A.
BLOOD, 2023, 142
[47] A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia
Ozmen, Deniz
Alpaydin, Duygu Demet
Saldogan, Muhammed Ali
Eskazan, Ahmet Emre
EXPERT OPINION ON DRUG SAFETY, 2024, 23 (04) : 411 - 423
[48] Tyrosine Kinase Inhibitors and Beyond for Chronic Myeloid Leukemia in Children
Lia N. Phillips
Nobuko Hijiya
Pediatric Drugs, 2021, 23 : 241 - 251
[49] The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Pophali, Priyanka A.
Patnaik, Mrinal M.
CANCER JOURNAL, 2016, 22 (01): : 40 - 50
[50] NEW AND ESTABLISHED TYROSINE KINASE INHIBITORS FOR CHRONIC MYELOID LEUKEMIA
Thienelt, C. D.
Green, K.
Bowles, D. W.
DRUGS OF TODAY, 2012, 48 (09) : 601 - 613

← 1 2 3 4 5 →